New RSV vaccine trial in puerto rico aims to protect little lungs
NCT ID NCT05687279
First seen Jan 29, 2026 · Last updated Apr 28, 2026 · Updated 14 times
Summary
This study tested a live, weakened RSV vaccine in healthy infants and toddlers aged 6 to 24 months in Puerto Rico. The main goal was to see if the vaccine virus spreads to others in the home or daycare, how much virus is shed, and if it stays genetically stable. Researchers also checked the vaccine's safety and how well it triggers an immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 6300001
San Juan, 00918, Puerto Rico
-
Investigational Site Number : 6300002
Carolina, 984, Puerto Rico
-
Investigational Site Number : 6300003
Guayama, 00784, Puerto Rico
-
Investigational Site Number : 6300004
Bayamón, 00960, Puerto Rico
-
Meridian Clinical Research Norfolk Site Number : 8400003
Norfolk, Nebraska, 68701, United States
-
Velocity Clinical Research, Omaha Site Number : 8400001
Omaha, Nebraska, 68134, United States
Conditions
Explore the condition pages connected to this study.